Assyro AI

FDA Orange Book · active-ingredient family

Olodaterol hydrochloride; tiotropium bromide

Olodaterol hydrochloride; tiotropium bromide is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:STIOLTO RESPIMAT · NDA 206756

1

Brand (NDA)

0

Generics (ANDA)

7

Listed patents

0

Exclusivity periods

Brand (NDA) products · spray, metered

ProductApplicantApplicationTEApproved
STIOLTO RESPIMATRLDBOEHRINGER INGELHEIMNDA 206756May 21, 2015

Listed patents (7)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7396341Oct 10, 2026in 4 mo
ProductDelisted
7727984Jan 19, 2027in 7 mo
Substance
9027967Mar 31, 2027in 10 mo
ProductDelisted
7396341*PEDApr 10, 2027in 10 mo
7837235Mar 13, 2028in 1 yr 9 mo
ProductDelisted
7837235*PEDSep 13, 2028in 2 yr 3 mo
8733341Oct 16, 2030in 4 yr 5 mo
ProductDelisted

Olodaterol hydrochloride; tiotropium bromide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.